In addition, Dupixent is approved to treat the following: corticosteroid-dependent asthma in children ages 6 years and older CRwNP in children ages 12 years and older atopic dermatitis (eczema ...

National Eczema Association: "Dupixent for Atopic Dermatitis FAQ ... dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials." Dupixent: "Dupixent ...

Atopic eczema often affects specific areas of the body, which vary depending on age: In infants and children ... This class of drugs — such as dupilumab (Dupixent) — targets specific parts ...

The study met its primary endpoint, but analysts compared the results unfavorably to the data on Dupixent. Adjusted for placebo, 19.1% of people on rocatinlimab had 75% improvement in eczema area ...